Consolidating Statements of Cash Flows (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income	$ 863,330	$ 757,201	$ 641,237
Changes in operating assets and liabilities and non cash items included in net income	596,077	1,016,140	459,611
Net cash provided by operating activities	1,459,407	1,773,341	1,100,848
Cash flows from investing activities:
Additions of property and equipment, net	(641,330)	(617,597)	(550,146)
Acquisitions	(272,094)	(310,394)	(4,294,077)
Proceeds from asset sales	8,791	62,258	3,559
Purchase of investments and other items	(373,096)	(11,149)	8,214
Net cash used in investing activities	(1,277,729)	(876,882)	(4,832,450)
Cash flows from financing activities:
Long-term debt and related financing costs, net	(7,989)	(438,007)	3,904,893
Other items	(156,990)	(44,984)	(32,509)
Net cash (used in) provided by financing activities	(164,979)	(482,991)	3,872,384
Effect of exchange rate changes on cash	2,293	(967)	(786)
Net increase (decrease) in cash and cash equivalents	18,992	412,501	139,996
Cash and cash equivalents at beginning of the year	946,249	533,748	393,752
Cash and cash equivalents at end of the year	965,241	946,249	533,748
DaVita HealthCare Partners Inc.
Cash flows from operating activities:
Net income	723,114	633,446	536,017
Changes in operating assets and liabilities and non cash items included in net income	(597,992)	(443,071)	(383,619)
Net cash provided by operating activities	125,122	190,375	152,398
Cash flows from investing activities:
Additions of property and equipment, net	(51,374)	(55,252)	(72,125)
Acquisitions			(3,645,760)
Proceeds from asset sales		60,650
Purchase of investments and other items	(333,803)	(4,944)	2,841
Net cash used in investing activities	(385,177)	454	(3,715,044)
Cash flows from financing activities:
Long-term debt and related financing costs, net	4,513	(421,739)	3,909,760
Intercompany borrowing	410,437	585,441	(586,050)
Other items	(58,207)	52,620	68,697
Net cash (used in) provided by financing activities	356,743	216,322	3,392,407
Net increase (decrease) in cash and cash equivalents	96,688	407,151	(170,239)
Cash and cash equivalents at beginning of the year	602,188	195,037	365,276
Cash and cash equivalents at end of the year	698,876	602,188	195,037
Guarantor Subsidiaries
Cash flows from operating activities:
Net income	647,085	522,778	487,077
Changes in operating assets and liabilities and non cash items included in net income	120,772	652,374	15,693
Net cash provided by operating activities	767,857	1,175,152	502,770
Cash flows from investing activities:
Additions of property and equipment, net	(312,191)	(337,042)	(305,885)
Acquisitions	(228,569)	(156,830)	(564,499)
Proceeds from asset sales	8,791	1,608	3,559
Purchase of investments and other items	(316)	(3,502)	(1,761)
Net cash used in investing activities	(532,285)	(495,766)	(868,586)
Cash flows from financing activities:
Long-term debt and related financing costs, net	(12,545)	(11,061)	(23,805)
Intercompany borrowing	(306,011)	(664,154)	580,825
Other items	(14,099)	4,726	(25,097)
Net cash (used in) provided by financing activities	(332,655)	(670,489)	531,923
Net increase (decrease) in cash and cash equivalents	(97,083)	8,897	166,107
Cash and cash equivalents at beginning of the year	175,004	166,107
Cash and cash equivalents at end of the year	77,921	175,004	166,107
Non-Guarantor Subsidiaries
Cash flows from operating activities:
Net income	475,907	397,259	323,195
Changes in operating assets and liabilities and non cash items included in net income	90,521	10,555	122,485
Net cash provided by operating activities	566,428	407,814	445,680
Cash flows from investing activities:
Additions of property and equipment, net	(277,765)	(225,303)	(172,136)
Acquisitions	(43,525)	(153,564)	(83,818)
Purchase of investments and other items	(38,977)	(2,703)	7,134
Net cash used in investing activities	(360,267)	(381,570)	(248,820)
Cash flows from financing activities:
Long-term debt and related financing costs, net	43	(5,207)	18,938
Intercompany borrowing	(104,426)	78,713	5,225
Other items	(84,684)	(102,330)	(76,109)
Net cash (used in) provided by financing activities	(189,067)	(28,824)	(51,946)
Effect of exchange rate changes on cash	2,293	(967)	(786)
Net increase (decrease) in cash and cash equivalents	19,387	(3,547)	144,128
Cash and cash equivalents at beginning of the year	169,057	172,604	28,476
Cash and cash equivalents at end of the year	188,444	169,057	172,604
Consolidating Adjustments
Cash flows from operating activities:
Net income	(982,776)	(796,282)	(705,052)
Changes in operating assets and liabilities and non cash items included in net income	$ 982,776	$ 796,282	$ 705,052